新冠肺炎住院患者的鼻出血
Epistaxis in hospitalized patients with COVID-19.
作者信息
Dell'Era Valeria, Dosdegani Riccardo, Valletti Paolo Aluffi, Garzaro Massimiliano
机构信息
ENT Division, University of Eastern Piedmont, Novara, Italy.
ENT Division, Sant'Andrea Hospital, Vercelli, Italy.
出版信息
J Int Med Res. 2020 Aug;48(8):300060520951040. doi: 10.1177/0300060520951040.
Spontaneous epistaxis in patients with COVID-19 can represent a clinical challenge with respect to both the risk of contamination and the treatment options. We herein present the data of 30 patients with COVID-19 who developed spontaneous epistaxis while hospitalized at Eastern Piedmont Hospital during March and April 2020. All patients received low-molecular-weight heparin during their hospital stay and required supplementary oxygen therapy either by a nasal cannula or continuous positive airway pressure. Both conditions can represent risk factors for developing epistaxis. Prevention of crust formation in patients with rhinitis using a nasal lubricant should be recommended. If any treatment is required, appropriate self-protection is mandatory.
新型冠状病毒肺炎（COVID-19）患者的自发性鼻出血在污染风险和治疗选择方面都可能带来临床挑战。我们在此呈现2020年3月至4月在皮埃蒙特东部医院住院期间发生自发性鼻出血的30例COVID-19患者的数据。所有患者在住院期间均接受了低分子量肝素治疗，并需要通过鼻导管或持续气道正压通气进行补充氧疗。这两种情况都可能是发生鼻出血的危险因素。应建议使用鼻用润滑剂预防鼻炎患者形成结痂。如果需要进行任何治疗，必须采取适当的自我防护措施。
Zotero 插件